These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 182889)

  • 1. Effect of cyclic 3',5'-guanosine monophosphate on human platelet function.
    Chiang TM; Dixit SN; Kang AH
    J Lab Clin Med; 1976 Aug; 88(2):215-21. PubMed ID: 182889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.
    Salzman EW; Levine L
    J Clin Invest; 1971 Jan; 50(1):131-41. PubMed ID: 4322665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of a chick skin collagen fragment (alpha1-CB5) with human platelets. Biochemical studies during the aggregation and release reaction.
    Chiang TM; Beachey EH; Kang AH
    J Biol Chem; 1975 Sep; 250(17):6916-22. PubMed ID: 169261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on platelet functions of derivatives of cyclic nucleotides.
    Pareti FI; Carrera D; Mannucci L; Mannucci PM
    Thromb Haemost; 1978 Apr; 39(2):404-10. PubMed ID: 209573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of the cyclic GMP concentration in human platelets by sodium ascorbate and 5-hydroxytryptamine.
    Schoepflin GS; Pickett W; Austen KF; Goetzl EJ
    J Cyclic Nucleotide Res; 1977 Oct; 3(5):355-65. PubMed ID: 201683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of beta 2-glycoprotein-I upon the content of cAMP and cGMP in human blood platelets.
    Nimpf J; Gries A; Wurm H; Kostner GM
    Thromb Haemost; 1985 Dec; 54(4):824-7. PubMed ID: 3003956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
    Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
    Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of cyclic adenosine monophosphate and guanosine monophosphate on the aggregation and nucleotide metabolism of the blood platelets].
    Nikulin AA
    Farmakol Toksikol; 1978; 41(2):177-82. PubMed ID: 207563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of protopine on rabbit platelet function].
    Ma GY; Zhang ZZ; Chen ZH
    Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):367-71. PubMed ID: 7801784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet adhesion to collagen by cGMP-elevating agents.
    Wu CC; Ko FN; Teng CM
    Biochem Biophys Res Commun; 1997 Feb; 231(2):412-6. PubMed ID: 9070290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function testing in the pony.
    Boudreaux MK; Wagner-Mann C; Purohit R; Hankes G; Spano J; Pablo L; Lee S; Conti J
    Lab Anim Sci; 1988 Aug; 38(4):448-51. PubMed ID: 3184855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
    Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
    Greenberg J; Packham MA; Cazenave JP; Reimers HJ; Mustard JF
    Lab Invest; 1975 Apr; 32(4):476-84. PubMed ID: 1127870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion.
    Gerrard JM; Townsend D; Stoddard S; Witkop CJ; White JG
    Am J Pathol; 1977 Jan; 86(1):99-116. PubMed ID: 188341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation.
    Hagiwara M; Endo T; Kanayama T; Hidaka H
    J Pharmacol Exp Ther; 1984 Feb; 228(2):467-71. PubMed ID: 6141286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic GMP but not cyclic AMP prevents renal platelet accumulation after ischemia-reperfusion in anesthetized rats.
    Chintala MS; Bernardino V; Chiu PJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1203-8. PubMed ID: 7996427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost.
    Anfossi G; Massucco P; Mularoni E; Cavalot F; Mattiello L; Trovati M
    Prostaglandins Leukot Essent Fatty Acids; 1993 Nov; 49(5):839-45. PubMed ID: 7508131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.